A 70-year-old woman with long-standing seropositive, nodular rheumatoid arthritis was commenced on adalimumab, a tumor necrosis factor- α (TNF-α) inhibitor for polyarthritis despite treatment with methotrexate and leflunomide. This evidence concerns the gene TNF and polyarticular arthritis.